Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin

Lisa W. Chu, Tamra E. Meyer, Qizhai Li, Idan Menashe, Kai Yu, Philip S. Rosenberg, Wen Yi Huang, Sabah M. Quraishi, Rudolf Kaaks, Jocelyn M. Weiss, Richard B. Hayes, Stephen J. Chanock, Ann W. Hsing

Research output: Contribution to journalArticle

Abstract

Background: Genome-wide association studies have identified multiple independent regions on chromosome 8q24 that are associated with cancers of the prostate, breast, colon, and bladder. Methods: To investigate their biological basis, we examined the possible association between 164 single nucleotide polymorphisms (SNPs) in the 8q24 risk regions spanning 128,101,433-128,828,043 bp, and serum androgen (testosterone, androstenedione, 3αdiol G, and bioavailable testosterone), and sex hormone-binding globulin levels in 563 healthy, non-Hispanic, Caucasian men (55-74 years old) from a prospective cohort study (the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial). Age-adjusted linear regression models were used to determine the association between the SNPs in an additive genetic model and log-transformed biomarker levels. Results: Three adjacent SNPs centromeric to prostate cancer risk-region 2 (rs12334903, rs1456310, and rs980171) were associated with testosterone (P <1.1 × 10-3) and bioavailable testosterone (P <6.3 × 10-4). Suggestive associations were seen for a cluster of nine SNPs in prostate cancer risk region 1 and androstenedione (P <0.05). Conclusions: These preliminary findings require confirmation in larger studies but raise the intriguing hypothesis that genetic variations in the 8q24 cancer risk regions might correlate with androgen levels. Impact: These results might provide some clues for the strong link between 8q24 and prostate cancer risk.

Original languageEnglish (US)
Pages (from-to)1848-1854
Number of pages7
JournalCancer Epidemiology Biomarkers and Prevention
Volume19
Issue number7
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Sex Hormone-Binding Globulin
Androgens
Prostatic Neoplasms
Single Nucleotide Polymorphism
Testosterone
Androstenedione
Neoplasms
Linear Models
Genome-Wide Association Study
Genetic Models
Early Detection of Cancer
Ovarian Neoplasms
Colorectal Neoplasms
Lung Neoplasms
Colon
Urinary Bladder
Cohort Studies
Chromosomes
Biomarkers
Prospective Studies

ASJC Scopus subject areas

  • Epidemiology
  • Oncology
  • Medicine(all)

Cite this

Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin. / Chu, Lisa W.; Meyer, Tamra E.; Li, Qizhai; Menashe, Idan; Yu, Kai; Rosenberg, Philip S.; Huang, Wen Yi; Quraishi, Sabah M.; Kaaks, Rudolf; Weiss, Jocelyn M.; Hayes, Richard B.; Chanock, Stephen J.; Hsing, Ann W.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 19, No. 7, 2010, p. 1848-1854.

Research output: Contribution to journalArticle

Chu, LW, Meyer, TE, Li, Q, Menashe, I, Yu, K, Rosenberg, PS, Huang, WY, Quraishi, SM, Kaaks, R, Weiss, JM, Hayes, RB, Chanock, SJ & Hsing, AW 2010, 'Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin', Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 7, pp. 1848-1854. https://doi.org/10.1158/1055-9965.EPI-10-0101
Chu, Lisa W. ; Meyer, Tamra E. ; Li, Qizhai ; Menashe, Idan ; Yu, Kai ; Rosenberg, Philip S. ; Huang, Wen Yi ; Quraishi, Sabah M. ; Kaaks, Rudolf ; Weiss, Jocelyn M. ; Hayes, Richard B. ; Chanock, Stephen J. ; Hsing, Ann W. / Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin. In: Cancer Epidemiology Biomarkers and Prevention. 2010 ; Vol. 19, No. 7. pp. 1848-1854.
@article{cfaf9d6cf895423abf5ab1a981a0a5d6,
title = "Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin",
abstract = "Background: Genome-wide association studies have identified multiple independent regions on chromosome 8q24 that are associated with cancers of the prostate, breast, colon, and bladder. Methods: To investigate their biological basis, we examined the possible association between 164 single nucleotide polymorphisms (SNPs) in the 8q24 risk regions spanning 128,101,433-128,828,043 bp, and serum androgen (testosterone, androstenedione, 3αdiol G, and bioavailable testosterone), and sex hormone-binding globulin levels in 563 healthy, non-Hispanic, Caucasian men (55-74 years old) from a prospective cohort study (the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial). Age-adjusted linear regression models were used to determine the association between the SNPs in an additive genetic model and log-transformed biomarker levels. Results: Three adjacent SNPs centromeric to prostate cancer risk-region 2 (rs12334903, rs1456310, and rs980171) were associated with testosterone (P <1.1 × 10-3) and bioavailable testosterone (P <6.3 × 10-4). Suggestive associations were seen for a cluster of nine SNPs in prostate cancer risk region 1 and androstenedione (P <0.05). Conclusions: These preliminary findings require confirmation in larger studies but raise the intriguing hypothesis that genetic variations in the 8q24 cancer risk regions might correlate with androgen levels. Impact: These results might provide some clues for the strong link between 8q24 and prostate cancer risk.",
author = "Chu, {Lisa W.} and Meyer, {Tamra E.} and Qizhai Li and Idan Menashe and Kai Yu and Rosenberg, {Philip S.} and Huang, {Wen Yi} and Quraishi, {Sabah M.} and Rudolf Kaaks and Weiss, {Jocelyn M.} and Hayes, {Richard B.} and Chanock, {Stephen J.} and Hsing, {Ann W.}",
year = "2010",
doi = "10.1158/1055-9965.EPI-10-0101",
language = "English (US)",
volume = "19",
pages = "1848--1854",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin

AU - Chu, Lisa W.

AU - Meyer, Tamra E.

AU - Li, Qizhai

AU - Menashe, Idan

AU - Yu, Kai

AU - Rosenberg, Philip S.

AU - Huang, Wen Yi

AU - Quraishi, Sabah M.

AU - Kaaks, Rudolf

AU - Weiss, Jocelyn M.

AU - Hayes, Richard B.

AU - Chanock, Stephen J.

AU - Hsing, Ann W.

PY - 2010

Y1 - 2010

N2 - Background: Genome-wide association studies have identified multiple independent regions on chromosome 8q24 that are associated with cancers of the prostate, breast, colon, and bladder. Methods: To investigate their biological basis, we examined the possible association between 164 single nucleotide polymorphisms (SNPs) in the 8q24 risk regions spanning 128,101,433-128,828,043 bp, and serum androgen (testosterone, androstenedione, 3αdiol G, and bioavailable testosterone), and sex hormone-binding globulin levels in 563 healthy, non-Hispanic, Caucasian men (55-74 years old) from a prospective cohort study (the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial). Age-adjusted linear regression models were used to determine the association between the SNPs in an additive genetic model and log-transformed biomarker levels. Results: Three adjacent SNPs centromeric to prostate cancer risk-region 2 (rs12334903, rs1456310, and rs980171) were associated with testosterone (P <1.1 × 10-3) and bioavailable testosterone (P <6.3 × 10-4). Suggestive associations were seen for a cluster of nine SNPs in prostate cancer risk region 1 and androstenedione (P <0.05). Conclusions: These preliminary findings require confirmation in larger studies but raise the intriguing hypothesis that genetic variations in the 8q24 cancer risk regions might correlate with androgen levels. Impact: These results might provide some clues for the strong link between 8q24 and prostate cancer risk.

AB - Background: Genome-wide association studies have identified multiple independent regions on chromosome 8q24 that are associated with cancers of the prostate, breast, colon, and bladder. Methods: To investigate their biological basis, we examined the possible association between 164 single nucleotide polymorphisms (SNPs) in the 8q24 risk regions spanning 128,101,433-128,828,043 bp, and serum androgen (testosterone, androstenedione, 3αdiol G, and bioavailable testosterone), and sex hormone-binding globulin levels in 563 healthy, non-Hispanic, Caucasian men (55-74 years old) from a prospective cohort study (the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial). Age-adjusted linear regression models were used to determine the association between the SNPs in an additive genetic model and log-transformed biomarker levels. Results: Three adjacent SNPs centromeric to prostate cancer risk-region 2 (rs12334903, rs1456310, and rs980171) were associated with testosterone (P <1.1 × 10-3) and bioavailable testosterone (P <6.3 × 10-4). Suggestive associations were seen for a cluster of nine SNPs in prostate cancer risk region 1 and androstenedione (P <0.05). Conclusions: These preliminary findings require confirmation in larger studies but raise the intriguing hypothesis that genetic variations in the 8q24 cancer risk regions might correlate with androgen levels. Impact: These results might provide some clues for the strong link between 8q24 and prostate cancer risk.

UR - http://www.scopus.com/inward/record.url?scp=77954526096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954526096&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-10-0101

DO - 10.1158/1055-9965.EPI-10-0101

M3 - Article

C2 - 20551303

AN - SCOPUS:77954526096

VL - 19

SP - 1848

EP - 1854

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 7

ER -